Cancers, Free Full-Text

The field of cancer research is famous for its incremental steps in improving therapy. The consistent but slow rate of improvement is greatly due to its meticulous use of consistent cancer biology models. However, as we enter an era of increasingly personalized cancer care, including chemo and radiotherapy, our cancer models must be equally able to be applied to all individuals. Patient-derived organoid (PDO) and organ-in-chip (OIC) models based on the micro-physiological bioengineered platform have already been considered key components for preclinical and translational studies. Accounting for patient variability is one of the greatest challenges in the crossover from preclinical development to clinical trials and patient derived organoids may offer a steppingstone between the two. In this review, we highlight how incorporating PDO’s and OIC’s into the development of cancer therapy promises to increase the efficiency of our therapeutics.

27+ Cancer Pictures Download Free Images & Stock Photos on Unsplash

Cancer-Free, Third Edition by Bill Henderson - Audiobook

Immunotherapy approaches for hematological cancers - ScienceDirect

Free PSD Breast cancer awareness editable text effect

Detection of HPV-16 DNA by PCR in histologically cancer free lymph

Cancer Awareness Word Search – Free Printable

Hypercalcemia and treated breast cancers: The diagnostic dilemma

Cancers, Free Full-Text

Information and Resources about for Cancer: Breast, Colon, Lung

Remission, cancer-free, no evidence of disease: What's the

Predicting peritoneal recurrence and disease-free survival from CT